Celldex Therapeutics
CLDX
CLDX
95 hedge funds and large institutions have $23.2M invested in Celldex Therapeutics in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 32 reducing their positions, and 16 closing their positions.
Holders
95
Holders Change
-7
Holders Change %
-6.86%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
21
Reduced
32
Closed
16
Calls
$11K
Puts
$13K
Net Calls
-$2K
Net Calls Change
+$47K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$2.41M |
| 2 |
GCP
2
GSA Capital Partners
London,
United Kingdom
|
$573K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$2.73M |
| 4 |
4
Two Sigma Investments
New York
|
$774K |
| 5 |
5
Two Sigma Advisers
New York
|
$288K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MSA
101
Marino Stram & Associates
Braintree,
Massachusetts
| $0 | 166 | – | – |
|
102
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
ASN
103
Advisory Services Network
Atlanta,
Georgia
| $0 | 260 | – | – |
|
104
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
HT
105
HAP Trading
New York
| – | – | – | – |
|
|
PMFA
106
Plante Moran Financial Advisors
Southfield,
Michigan
| $0 | 8 | – | – |
|
|
IA
107
IFP Advisors
Tampa,
Florida
| $0 | 900 | – | – |
|
|
FWM
108
Focused Wealth Management
Newburgh,
New York
| $0 | 350 | – | – |
|
|
ML
109
McAdam LLC
Philadelphia,
Pennsylvania
| $0 | 42 | – | – |
|
|
SWP
110
Strategic Wealth Partners
Independence,
Ohio
| $0 | 1,000 | – | – |
|
|
CFGS
111
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
112
Walleye Trading
New York
| $0 | 40 | +40 | New |
|
|
KF
113
Krilogy Financial
St. Louis,
Missouri
| $0 | 600 | +600 | New |
|
114
JPMorgan Chase & Co
New York
| $0 | 1,893 | +893 | +89% |
|
|
RMAM
115
Raab & Moskowitz Asset Management
Chatham,
New Jersey
| $0 | 1,000 | +1,000 | New |
|